Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Sondel

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Cellular Immunology|August 1, 1975
Immunologic functions of isolated human lymphocyte subpopulations. IV. Stimulation of MLC and CML by human T cellsP M Sondel, L Chess, S F Schlossman
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
BLT-esterase activity following in vitro and in vivo activation of human lymphocytes with interleukin-2. In vivo IL-2 induces BLT-esteraseA Cannon, J A Hank, P M Sondel
Blood|July 15, 1994
Addendum to SCID, interleukin-2, and the interleukin-2 receptor reviewP M Sondel, S D Voss, R Hong
Human Immunology|January 1, 1987
Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell linesB P Chen, R DeMars, P M Sondel
Human Immunology|July 1, 1985
The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genesP J Reitnauer, R DeMars, P M Sondel
Human Immunology|July 1, 1986
The proliferative immune response to autologous Epstein-Barr virus transformed lymphoblastoid cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQP J Reitnauer, R DeMars, P M Sondel
Blood|February 1, 1994
Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the wayS D Voss, R Hong, P M Sondel
Bone Marrow Transplantation|January 1, 1992
Harnessing graft versus leukemia: implications for IL-2 treatmentP M Sondel, H Kawai, O H Wesly
Haematology and Blood Transfusion|January 1, 1979
Elicitation of anti-leukemia cytotoxic responsesF H Bach, P M Sondel, J M Zarling
Diseases of the Colon and Rectum|July 1, 1987
Reduced incidence of hepatic metastases by perioperative treatment with recombinant human interleukin-2J L Weese, S E Emoto, P M Sondel
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Cellular Immunology|August 1, 1975
Immunologic functions of isolated human lymphocyte subpopulations. IV. Stimulation of MLC and CML by human T cellsP M Sondel, L Chess, S F Schlossman
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
BLT-esterase activity following in vitro and in vivo activation of human lymphocytes with interleukin-2. In vivo IL-2 induces BLT-esteraseA Cannon, J A Hank, P M Sondel
Blood|July 15, 1994
Addendum to SCID, interleukin-2, and the interleukin-2 receptor reviewP M Sondel, S D Voss, R Hong
Human Immunology|January 1, 1987
Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell linesB P Chen, R DeMars, P M Sondel
Human Immunology|July 1, 1985
The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genesP J Reitnauer, R DeMars, P M Sondel
Human Immunology|July 1, 1986
The proliferative immune response to autologous Epstein-Barr virus transformed lymphoblastoid cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQP J Reitnauer, R DeMars, P M Sondel
Blood|February 1, 1994
Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the wayS D Voss, R Hong, P M Sondel
Bone Marrow Transplantation|January 1, 1992
Harnessing graft versus leukemia: implications for IL-2 treatmentP M Sondel, H Kawai, O H Wesly
Haematology and Blood Transfusion|January 1, 1979
Elicitation of anti-leukemia cytotoxic responsesF H Bach, P M Sondel, J M Zarling
Diseases of the Colon and Rectum|July 1, 1987
Reduced incidence of hepatic metastases by perioperative treatment with recombinant human interleukin-2J L Weese, S E Emoto, P M Sondel
Pageof 22